Description: In the face of the ongoing Israeli-Palestinian conflict, the India-Israel pharmaceutical trade is displaying remarkable resilience. In the 2022-23 period, pharmaceutical exports from India to Israel surged to $92 million from $60 million the previous year, showcasing a significant upward trajectory. Abhishek Singh, CEO of Taj Pharmaceuticals, offers invaluable insights into the reasons behind this resilience, shedding light on why the conflict’s impact on India’s pharmaceutical exports to Israel might be less severe than anticipated. The Indian pharmaceutical industry has established itself as a prominent global player. India primarily exports bulk drugs (API), drug formulations, and biologicals to Israel. However, Israel possesses a well-regulated pharmaceutical market, reducing its immediate dependence on Indian counterparts. Abhishek Singh highlights the minimal nature of pharmaceutical trade between the two countries, stating, “At present, I don’t see any huge impact on the pharmaceutical trade between India and Israel.” The ongoing Israeli-Palestinian conflict raises concerns about the pharmaceutical trade’s stability, particularly in the Middle East and North Africa (MENA) region. The conflict could disrupt pharmaceutical exports to nations like the UAE, Qatar, Saudi Arabia, Egypt, and Bahrain, which represent significant destinations for Indian pharmaceutical products. These experts estimate that a prolonged conflict could disrupt the supply chain, affecting the entire spectrum of the pharmaceutical industry, from small to large-scale businesses. Despite the self-sufficiency of Israel’s pharmaceutical industry, companies like Taro and Teva, Taj Pharmaceuticals, a major player in the MENA region, could face significant disruptions. Certain pharmaceutical companies are actively seeking ways to minimize the impact on their operations in the affected regions. In conclusion, while the Israeli-Palestinian conflict remains a critical international issue, India’s pharmaceutical trade with Israel appears poised to weather the storm. Abhishek Singh’s insights highlight the strength of the pharmaceutical industry and its resilience in the face of challenges.
Dimensions: 2560 x 1689
File Type: jpeg
File Size: 614 KB
